Quick Takeaways
- Bpifrance Participations SA filed SCHEDULE 13D/A for Innate Pharma SA Ordinary Shares, nominal value EUR0.05 per share (IPHA).
- Disclosed ownership: 7.9%.
- Date of event: 25 Apr 2025.
Quoteable Key Fact
"Bpifrance Participations SA disclosed 7.9% ownership in Innate Pharma SA Ordinary Shares, nominal value EUR0.05 per share (IPHA) on 25 Apr 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bpifrance Participations S.A. | 6.9% | 6,389,406 | 0 | 6,389,406 | Sophie Paquin | Director of Legal Affairs | 0001581835 |
| CDC Croissance S.A. | 1% | 930,023 | 0 | 930,023 | Aude de Lardemelle | Executive Director | |
| Caisse des depots et consignations | 7.9% | 7,319,429 | 0 | 7,319,429 | Laurence Giraudon | Chief Operating Officer, Finance and Operations Department, Asset Management Division | 0001056947 |
| EPIC Bpifrance | 6.9% | 6,389,406 | 0 | 6,389,406 | Sophie Paquin | Director of Legal Affairs | |
| Bpifrance S.A. | 6.9% | 6,389,406 | 0 | 6,389,406 | Boubakar Dione | Group Director of Legal Affairs | 0001731118 |